Use of estrogen antagonists and estrogen agonists in inhibiting

Details Use of estrogen antagonists and estrogen agonists in inhibiting Use of estrogen antagonists and estrogen agonists in inhibiting

1997-02-21

2000-08-22

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514427, A61K 3140

Patent

active

061073318

ABSTRACT:
The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1##

REFERENCES:
patent: 4418068 (1983-11-01), Jones
patent: 4859585 (1989-08-01), Sonnenschein
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5254594 (1993-10-01), Kazuaki et al.
patent: 5364791 (1994-11-01), Vegeto et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5389670 (1995-02-01), Fontana
patent: 5391557 (1995-02-01), Cullinan et al.
patent: 5393763 (1995-02-01), Black et al.
patent: 5418252 (1995-05-01), Williams
patent: 5434166 (1995-07-01), Glasebrook
patent: 5439923 (1995-08-01), Cullinan
patent: 5439931 (1995-08-01), Sales
patent: 5441966 (1995-08-01), Dodge
patent: 5441986 (1995-08-01), Thompson
patent: 5446053 (1995-08-01), Koehane
patent: 5447941 (1995-09-01), Zuckerman
patent: 5451589 (1995-09-01), Dodge
patent: 5451590 (1995-09-01), Dodge
patent: 5455275 (1995-10-01), Fontana
patent: 5457113 (1995-10-01), Cullinan
patent: 5457116 (1995-10-01), Black et al.
patent: 5457117 (1995-10-01), Black et al.
patent: 5461064 (1995-10-01), Cullinan
patent: 5461065 (1995-10-01), Black et al.
patent: 5462937 (1995-10-01), Cullinan et al.
patent: 5462949 (1995-10-01), Jones et al.
patent: 5462950 (1995-10-01), Fontana
patent: 5464845 (1995-11-01), Black et al.
patent: 5470883 (1995-11-01), Stromberg
patent: 5550164 (1996-08-01), Fontana
patent: 5552412 (1996-09-01), Cameron et al.
Klaus, S. et al. "In Vivo and in Vitro Antiestrogenic Action of 3-Hydroxytamoxifen, Tamocifen and 4-Hydroxytamoxifen," Eur. J. Cancer Clin. Oncol., vol. 21, No. 8, pp. 985-990, 1985.
Eppenberger, U. et al. "Pharmacologic and Biologic Properties of Droloxifene, A New Antiestrogen," Am. J. Clin. Oncol (CCT) 14, Suppl. 2, pp. S5-S14, 1991.
Stedman's Medical Dictionary, 25th Edition (1990), pp. 628, 676, 745, 926 and 1239.

Affiliated with

Also associated with

Rating

Use of estrogen antagonists and estrogen agonists in inhibiting does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of estrogen antagonists and estrogen agonists in inhibiting , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of estrogen antagonists and estrogen agonists in inhibiting will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-581586